The DNA methylation levels of the ABCA1 promoter are elevated in familial hypercholesterolemia, correlating with reduced circulating HDL-C levels and a higher risk of CAD (Guay et al., 2012). The gene discussed is ABCA1; the disease is coronary artery disorder.